The Use of Oral Recombinant Feline Interferon Omega in Two Cats with Type II Diabetes Mellitus and Concurrent Feline Chronic Gingivostomatitis Syndrome

    October 2013 in “ Irish Veterinary Journal ”
    Rodolfo Oliveira Leal, Solange Gil, Maria Teresa Villa de Brito, David McGahie, Maria M. R. E. Niza, Luís Tavares
    TLDR Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.
    The document described the use of oral recombinant feline interferon omega (rFeIFN-ω) in treating two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome (FCGS). The treatment led to significant clinical improvement in FCGS symptoms, including reduced pain and improved mastication, around 60 days after therapy onset. This case study suggested that rFeIFN-ω could be a viable alternative to corticosteroids for managing FCGS in diabetic cats, although the small sample size limited the generalizability of the findings. Further research with a larger sample size would be necessary to confirm these preliminary results.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 8 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Tropoelastin injections + verteporfin?

      in Research/Science  13 upvotes 1 year ago
      The use of tropoelastin injections and verteporfin for hair transplant recipients to help regrow donor area hairs, as well as research done on tropoelastin injections restoring elastin in scarred heart tissue and skin. There are discussions about why it is taking so long to get cosmetic mass produced tropoelastin injectables on the market.

      community Androgen degraders for hair loss

      in Research/Science  62 upvotes 3 months ago
      The conversation discusses androgen receptor degraders for hair loss, highlighting their potential advantages over traditional AR blockers like RU58841 and pyrilutamide. Concerns about the safety and cost of these treatments are also mentioned.

    Similar Research

    5 / 1000+ results